University Clinic of Cardiology, Medical Faculty, University Ss. Cyril and Methodius, Skopje, Macedonia.
Contego Medical, LLC, Raleigh, NC, United States of America.
Cardiovasc Revasc Med. 2024 Jun;63:43-51. doi: 10.1016/j.carrev.2024.01.006. Epub 2024 Jan 12.
The highest rate of embolization during carotid artery stenting occurs during post-dilation. We evaluated the ability of the Paladin system (Contego Medical, Raleigh, NC), a novel PTA balloon with an integrated 40-ɥm pore filter, to collect microemboli that may pass into the cerebral circulation when used during post-dilation.
25 symptomatic patients underwent transradial CAS using the Paladin system in conjunction with the Roadsaver (Terumo Corporation, Tokyo, Japan) micromesh stent. No additional embolic protection was used. The Paladin filters were collected following the procedure and preserved in formalin for histological analysis. The contents were evaluated for particle count and size. Subjects were followed for 30 days and evaluated for major cardiac adverse events (death, stroke and MI). Secondary endpoints included procedure success, device success, access site complications according to EASY score classification, major vascular or ischemic complications at follow up and in-stent restenosis rate evaluated with duplex ultrasound.
Mean age of patients was 68,5 years. Type 2 aortic arch was present in 77 % of patients and type 1 and type 3 in 12 % and 11 % of patients respectively. Procedural and device success was obtained in all cases without complications. The 30-day MAE rate was 0 %. Twenty-three filters underwent histological analysis. Microscopic debris was present in 100 % of filters, and 75 % of particles were less than 100ɥm in size. The mean number of particles per filter was 3352 ± 1567 (IQR 4300-2343), and the mean number of particles between 40-100ɥm per filter was 2499 ± 1240 (IQR 3227-1575).
CAS through radial approach can be safely and effectively performed using the IEP technology Paladin device and double-layer micromesh Roadsaver stent. This strategy can simplify the procedure and decrease peri-procedural complications and procedural time.
颈动脉支架置入术中,后扩张期间的栓塞发生率最高。我们评估了 Paladin 系统(Contego Medical,Raleigh,NC)的能力,这是一种新型的 PTA 球囊,带有集成的 40-μm 孔过滤器,当在后扩张期间使用时,可以收集可能进入脑循环的微栓子。
25 名有症状的患者经桡动脉途径使用 Paladin 系统联合 Roadsaver(Terumo 公司,东京,日本)微网支架进行了 CAS。未使用其他栓塞保护装置。在手术后收集 Paladin 过滤器并保存在福尔马林中进行组织学分析。评估颗粒计数和大小。对患者进行 30 天随访,评估主要心脏不良事件(死亡、卒中和 MI)。次要终点包括程序成功、器械成功、根据 EASY 评分分类的入路部位并发症、随访时的主要血管或缺血性并发症以及使用双功超声评估的支架内再狭窄率。
患者的平均年龄为 68.5 岁。77%的患者存在 2 型主动脉弓,12%和 11%的患者分别存在 1 型和 3 型主动脉弓。所有病例均无并发症获得程序和器械成功。30 天 MAE 发生率为 0%。23 个过滤器进行了组织学分析。100%的过滤器中存在微观碎片,75%的颗粒小于 100μm。每个过滤器的平均颗粒数为 3352±1567(IQR 4300-2343),每个过滤器中 40-100μm 的平均颗粒数为 2499±1240(IQR 3227-1575)。
经桡动脉途径行 CAS 可安全、有效地使用 IEP 技术的 Paladin 装置和双层微网 Roadsaver 支架进行。这种策略可以简化手术过程,减少围手术期并发症和手术时间。